InB:Biotechnologies, Inc., a wholly-owned subsidiary of Integrated BioPharma, Inc. (Nasdaq:INBP), announced today that prototypes of the Company's influenza subunit vaccines provided complete protection against infection in the ferret challenge model and proved highly immunogenic in a mouse model. The ferret model is the industry standard for studying influenza infections and for testing flu vaccine candidates.
More checkbiotech
Did you enjoy this article? Link it!

Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place. ISSN 1802-2685.
© 2006 South Moravian Innovation Centre
Sitemaps.org | RSS web feeds | HTML Sitemap | Newsletter subscription | Send this page to a friend
Interesting biotechnology content:
CVUT - Czech Technical University
The International Service for the Acquisition of Agri-biotech Applications (ISAAA) report